Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data

The Elston–Stewart peeling algorithm enables estimation of an individual's probability of harboring germline risk alleles based on pedigree data, and serves as the computational backbone of important genetic counseling tools. However, it remains limited to the analysis of risk alleles at a small number of genetic loci because its computing time grows exponentially with the number of loci considered. We propose a novel, approximate version of this algorithm, dubbed the peeling and paring algorithm, which scales polynomially in the number of loci. This allows extending peeling‐based models to include many genetic loci. The algorithm creates a trade‐off between accuracy and speed, and allows the user to control this trade‐off. We provide exact bounds on the approximation error and evaluate it in realistic simulations. Results show that the loss of accuracy due to the approximation is negligible in important applications. This algorithm will improve genetic counseling tools by increasing the number of pathogenic risk alleles that can be addressed. To illustrate we create an extended five genes version of BRCAPRO, a widely used model for estimating the carrier probabilities of BRCA1 and BRCA2 risk alleles and assess its computational properties.

[1]  J. Stockman,et al.  Risk of Pancreatic Cancer in Families With Lynch Syndrome , 2011 .

[2]  C. Halbert,et al.  Decisions and outcomes of genetic testing for inherited breast cancer risk. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Michael I. Jordan,et al.  Loopy Belief Propagation for Approximate Inference: An Empirical Study , 1999, UAI.

[4]  Jr. G. Forney,et al.  Viterbi Algorithm , 1973, Encyclopedia of Machine Learning.

[5]  Donavan T. Cheng,et al.  Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. , 2016, JAMA oncology.

[6]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[7]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[8]  E. Lander,et al.  Construction of multilocus genetic linkage maps in humans. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H A Risch,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.

[10]  E. Murphy,et al.  The Application of Bayesian Methods in Genetic Counselling , 1969 .

[11]  Giovanni Parmigiani,et al.  A two-stage approach to genetic risk assessment in primary care , 2016, Breast Cancer Research and Treatment.

[12]  R. Elston,et al.  A general model for the genetic analysis of pedigree data. , 1971, Human heredity.

[13]  Robert Roberts,et al.  A genetic basis for coronary artery disease. , 2015, Trends in cardiovascular medicine.

[14]  Christoph Lange,et al.  Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. , 2014, The Lancet. Respiratory medicine.

[15]  D. Haber,et al.  Hereditary breast cancer. , 1998, Annual review of medicine.

[16]  Jr. G. Forney,et al.  The viterbi algorithm , 1973 .

[17]  Alexander Gutin,et al.  Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. , 2017, JCO precision oncology.

[18]  Rongwei Fu,et al.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation , 2014, Annals of Internal Medicine.

[19]  Nazneen Rahman,et al.  Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.

[20]  Giovanni Parmigiani,et al.  Penetrance of ATM Gene Mutations in Breast Cancer: A Meta‐Analysis of Different Measures of Risk , 2016, Genetic epidemiology.

[21]  D. Easton,et al.  BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients , 2011, British Journal of Cancer.

[22]  Sofia Khan,et al.  Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations , 2011, Familial Cancer.

[23]  Henry T. Lynch,et al.  Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review , 2014, Current Treatment Options in Oncology.

[24]  Giovanni Parmigiani,et al.  Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO , 2015, Cancer informatics.

[25]  Bauke Ylstra,et al.  Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities. , 2017, JCO precision oncology.

[26]  D. Euhus Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling , 2001, The breast journal.

[27]  Julie O. Culver,et al.  Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors , 2012, Journal of Genetic Counseling.

[28]  A. V. Favorov,et al.  A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches , 2015, Human Genetics.

[29]  D. Berry,et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.

[30]  Todd C. Handy,et al.  Effects of adjuvant 5FU/oxaliplatin chemotherapy in individuals treated for colon cancer on cognitive and mobility function. , 2016 .

[31]  Danielle Braun,et al.  A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations , 2018, Journal of Genetic Counseling.

[32]  S. Syngal,et al.  Inherited colorectal cancer syndromes. , 2011, Cancer journal.

[33]  L. Groop,et al.  Genetics of Type 2 Diabetes—Pitfalls and Possibilities , 2015, Genes.

[34]  Molly Griffin,et al.  What's New in Genetic Testing for Cancer Susceptibility? , 2016, Oncology.

[35]  Michael Jones,et al.  Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Judea Pearl,et al.  Reverend Bayes on Inference Engines: A Distributed Hierarchical Approach , 1982, AAAI.

[37]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Giovanni Parmigiani,et al.  Simplifying clinical use of the genetic risk prediction model BRCAPRO , 2013, Breast Cancer Research and Treatment.

[39]  Karl W Broman,et al.  BayesMendel: an R Environment for Mendelian Risk Prediction , 2004, Statistical applications in genetics and molecular biology.

[40]  H T Lynch,et al.  Hereditary breast cancer. , 1991, Annals of medicine.

[41]  Michael Goggins,et al.  Update on familial pancreatic cancer. , 2010, Advances in surgery.

[42]  D. Schaid Mathematical and Statistical Methods for Genetic Analysis , 1999 .